Floatz logo

Triticum Aestivum

Vascular Risk

Coordinación de Investigación en Salud, MexicoPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Vascular Risk cohort.

Asset / SponsorPhaseRating
Calcined Magnesia
Coordinación de Investigación en Salud, Mexico
Phase 3BB
Empagliflozin
VA Office of Research and Development
Phase 2CCC
Kln-1010
Kelonia Therapeutics, Inc.
Phase 1CC

Same molecule, other indications

Triticum Aestivum is also rated in:

obesity due to congenital leptin deficiencyDormant
B
Indicative ·
60 / 100
View asset →
obesity disorderDormant
CCC
Indicative ·
52 / 100
View asset →
AdiponectinDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →